These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 17210458)

  • 21. Species differences of bombesin analog interactions with GRP-R define the choice of animal models in the development of GRP-R-targeting drugs.
    Maina T; Nock BA; Zhang H; Nikolopoulou A; Waser B; Reubi JC; Maecke HR
    J Nucl Med; 2005 May; 46(5):823-30. PubMed ID: 15872357
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new high affinity technetium-99m-bombesin analogue with low abdominal accumulation.
    Lin KS; Luu A; Baidoo KE; Hashemzadeh-Gargari H; Chen MK; Brenneman K; Pili R; Pomper M; Carducci MA; Wagner HN
    Bioconjug Chem; 2005; 16(1):43-50. PubMed ID: 15656574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel series of (177)Lu-labeled bombesin derivatives with amino acidic spacers for selective targeting of human PC-3 prostate tumor cells.
    Pujatti PB; Santos JS; Couto RM; Melero LT; Suzuki MF; Soares CR; Grallert SR; Mengatti J; De Araújo EB
    Q J Nucl Med Mol Imaging; 2011 Jun; 55(3):310-23. PubMed ID: 21532543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and radiopharmacological evaluation of ⁶⁴Cu-labeled bombesin analogs featuring a bis(2-pyridylmethyl)-1,4,7-triazacyclononane chelator.
    Bergmann R; Ruffani A; Graham B; Spiccia L; Steinbach J; Pietzsch J; Stephan H
    Eur J Med Chem; 2013; 70():434-46. PubMed ID: 24184988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PEG spacers of different length influence the biological profile of bombesin-based radiolabeled antagonists.
    Jamous M; Tamma ML; Gourni E; Waser B; Reubi JC; Maecke HR; Mansi R
    Nucl Med Biol; 2014 Jul; 41(6):464-70. PubMed ID: 24780298
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potent bombesin-like peptides for GRP-receptor targeting of tumors with 99mTc: a preclinical study.
    Nock BA; Nikolopoulou A; Galanis A; Cordopatis P; Waser B; Reubi JC; Maina T
    J Med Chem; 2005 Jan; 48(1):100-10. PubMed ID: 15634004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spacer site modifications for the improvement of the in vitro and in vivo binding properties of (99m)Tc-N(3)S-X-bombesin[2-14] derivatives.
    Fragogeorgi EA; Zikos C; Gourni E; Bouziotis P; Paravatou-Petsotas M; Loudos G; Mitsokapas N; Xanthopoulos S; Mavri-Vavayanni M; Livaniou E; Varvarigou AD; Archimandritis SC
    Bioconjug Chem; 2009 May; 20(5):856-67. PubMed ID: 19344122
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro and in vivo evaluation of a 99mTc(I)-labeled bombesin analogue for imaging of gastrin releasing peptide receptor-positive tumors.
    La Bella R; Garcia-Garayoa E; Langer M; Bläuenstein P; Beck-Sickinger AG; Schubiger PA
    Nucl Med Biol; 2002 Jul; 29(5):553-60. PubMed ID: 12088725
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and evaluation of bombesin derivatives on the basis of pan-bombesin peptides labeled with indium-111, lutetium-177, and yttrium-90 for targeting bombesin receptor-expressing tumors.
    Zhang H; Chen J; Waldherr C; Hinni K; Waser B; Reubi JC; Maecke HR
    Cancer Res; 2004 Sep; 64(18):6707-15. PubMed ID: 15374988
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preparation of cyclotron-produced 186Re and comparison with reactor-produced 186Re and generator-produced 188Re for the labeling of bombesin.
    Moustapha ME; Ehrhardt GJ; Smith CJ; Szajek LP; Eckelman WC; Jurisson SS
    Nucl Med Biol; 2006 Jan; 33(1):81-9. PubMed ID: 16459262
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preclinical evaluation of a new, stabilized neurotensin(8--13) pseudopeptide radiolabeled with (99m)tc.
    García-Garayoa E; Bläuenstein P; Bruehlmeier M; Blanc A; Iterbeke K; Conrath P; Tourwé D; Schubiger PA
    J Nucl Med; 2002 Mar; 43(3):374-83. PubMed ID: 11884498
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of (99m)Tc-HYNIC-βAla-Bombesin(7-14) as an agent for pancreas tumor detection in mice.
    Carlesso FN; Fuscaldi LL; Araújo RS; Teixeira CS; Oliveira MC; Fernandes SO; Cassali GD; Reis DC; Barros AL; Cardoso VN
    Braz J Med Biol Res; 2015 Oct; 48(10):923-8. PubMed ID: 26445336
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preparation and first biological evaluation of novel Re-188/Tc-99m peptide conjugates with substance-P.
    Smilkov K; Janevik E; Guerrini R; Pasquali M; Boschi A; Uccelli L; Di Domenico G; Duatti A
    Appl Radiat Isot; 2014 Sep; 92():25-31. PubMed ID: 24973465
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radionuclide imaging of small-cell lung cancer (SCLC) using 99mTc-labeled neurotensin peptide 8-13.
    Zhang K; An R; Gao Z; Zhang Y; Aruva MR
    Nucl Med Biol; 2006 May; 33(4):505-12. PubMed ID: 16720242
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of linking substituents on the in vivo behavior of site-directed, peptide-based, diagnostic radiopharmaceuticals.
    Prasanphanich AF; Lane SR; Figueroa SD; Ma L; Rold TL; Sieckman GL; Hoffman TJ; McCrate JM; Smith CJ
    In Vivo; 2007; 21(1):1-16. PubMed ID: 17354608
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A new high affinity technetium analogue of bombesin containing DTPA as a pharmacokinetic modifier.
    Lin KS; Luu A; Baidoo KE; Hashemzadeh-Gargari H; Chen MK; Pili R; Pomper M; Carducci M; Wagner HN
    Bioconjug Chem; 2004; 15(6):1416-23. PubMed ID: 15546210
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiochemical investigations of gastrin-releasing peptide receptor-specific [(99m)Tc(X)(CO)3-Dpr-Ser-Ser-Ser-Gln-Trp-Ala-Val-Gly-His-Leu-Met-(NH2)] in PC-3, tumor-bearing, rodent models: syntheses, radiolabeling, and in vitro/in vivo studies where Dpr = 2,3-diaminopropionic acid and X = H2O or P(CH2OH)3.
    Smith CJ; Sieckman GL; Owen NK; Hayes DL; Mazuru DG; Kannan R; Volkert WA; Hoffman TJ
    Cancer Res; 2003 Jul; 63(14):4082-8. PubMed ID: 12874010
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preparation and evaluation of bombesin peptide derivatives as potential tumor imaging agents: effects of structure and composition of amino acid sequence on in vitro and in vivo characteristics.
    Okarvi SM; Jammaz IA
    Nucl Med Biol; 2012 Aug; 39(6):795-804. PubMed ID: 22381782
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and evaluation of bombesin analogues conjugated to two different triazolyl-derived chelators for (99m)Tc labeling.
    Brans L; García-Garayoa E; Schweinsberg C; Maes V; Struthers H; Schibli R; Tourwé D
    ChemMedChem; 2010 Oct; 5(10):1717-25. PubMed ID: 20806312
    [TBL] [Abstract][Full Text] [Related]  

  • 40. GRP receptor-targeted PET of a rat pancreas carcinoma xenograft in nude mice with a 68Ga-labeled bombesin(6-14) analog.
    Schuhmacher J; Zhang H; Doll J; Mäcke HR; Matys R; Hauser H; Henze M; Haberkorn U; Eisenhut M
    J Nucl Med; 2005 Apr; 46(4):691-9. PubMed ID: 15809493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.